Literature DB >> 31972370

A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy.

Luigi Vetri1, Francesco Calì2, Mirella Vinci2, Carmelo Amato2, Michele Roccella3, Tiziana Granata4, Elena Freri4, Roberta Solazzi4, Valentino Romano5, Maurizio Elia6.   

Abstract

An increasing number of developmental and epileptic encephalopathies have been correlated with variants of ion channel genes, and in particular of potassium channels genes, such as KCNA1, KCNA2, KCNB1, KCNQ2, KCTD7 and KCNT1. Here we report a child with an early severe developmental and epileptic encephalopathy, spastic tetraplegia, opisthotonos attacks. The whole exome sequencing showed the de novo heterozygous variant c.1411G > C (p.Val471Leu) in the KCNC2 gene. Although this is, to our knowledge, the first case of encephalopathy associated with a KCNC2 gene variant, and further confirmatory studies are needed, previous preclinical and clinical evidence seems to suggest that KCNC2 is a new candidate epilepsy gene.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Developmental and epileptic encephalopathies; EEG; Exome; KCNC2; Kv3.2; NGS

Mesh:

Substances:

Year:  2020        PMID: 31972370     DOI: 10.1016/j.ejmg.2020.103848

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  5 in total

1.  Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants.

Authors:  Niklas Schwarz; Simone Seiffert; Manuela Pendziwiat; Annika Verena Rademacher; Tobias Brünger; Ulrike B S Hedrich; Paul B Augustijn; Hartmut Baier; Allan Bayat; Francesca Bisulli; Russell J Buono; Ben Zeev Bruria; Michael G Doyle; Renzo Guerrini; Gali Heimer; Michele Iacomino; Hugh Kearney; Karl Martin Klein; Ioanna Kousiappa; Wolfram S Kunz; Holger Lerche; Laura Licchetta; Ebba Lohmann; Raffaella Minardi; Marie McDonald; Sarah Montgomery; Lejla Mulahasanovic; Renske Oegema; Barel Ortal; Savvas S Papacostas; Francesca Ragona; Tiziana Granata; Phillip S Reif; Felix Rosenow; Annick Rothschild; Paolo Scudieri; Pasquale Striano; Paolo Tinuper; George A Tanteles; Annalisa Vetro; Felix Zahnert; Ethan M Goldberg; Federico Zara; Dennis Lal; Patrick May; Hiltrud Muhle; Ingo Helbig; Yvonne Weber
Journal:  Neurology       Date:  2022-03-21       Impact factor: 11.800

2.  Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long-read sequencing.

Authors:  Elvisa Mehinovic; Teddi Gray; Meghan Campbell; Jenny Ekholm; Aaron Wenger; William Rowell; Ari Grudo; Jane Grimwood; Jonas Korlach; Christina Gurnett; John N Constantino; Tychele N Turner
Journal:  Am J Med Genet A       Date:  2022-04-02       Impact factor: 2.578

3.  Personalized structural biology reveals the molecular mechanisms underlying heterogeneous epileptic phenotypes caused by de novo KCNC2 variants.

Authors:  Souhrid Mukherjee; Thomas A Cassini; Ningning Hu; Tao Yang; Bian Li; Wangzhen Shen; Christopher W Moth; David C Rinker; Jonathan H Sheehan; Joy D Cogan; John H Newman; Rizwan Hamid; Robert L Macdonald; Dan M Roden; Jens Meiler; Georg Kuenze; John A Phillips; John A Capra
Journal:  HGG Adv       Date:  2022-07-19

4.  Emerging evidence of genotype-phenotype associations of developmental and epileptic encephalopathy due to KCNC2 mutation: Identification of novel R405G.

Authors:  Sumei Wang; Yejing Yu; Xu Wang; Xiaolong Deng; Jiehui Ma; Zhisheng Liu; Weiyue Gu; Dan Sun
Journal:  Front Mol Neurosci       Date:  2022-08-25       Impact factor: 6.261

5.  Exome sequencing in a child with neurodevelopmental disorder and epilepsy: Variant analysis of the AHNAK2 gene.

Authors:  Mirella Vinci; Petri Kursula; Donatella Greco; Maurizio Elia; Luigi Vetri; Carmelo Schepis; Valeria Chiavetta; Serena Donadio; Michele Roccella; Marco Carotenuto; Valentino Romano; Francesco Calì
Journal:  Mol Genet Genomic Med       Date:  2022-07-05       Impact factor: 2.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.